Company Filing History:
2 out of 5,081 
2 out of 4 
1 out of 870 
Years Active: 2010-2013
Title: Sylvie Gerbaud: Innovator in Coronavirus Research
Introduction
Sylvie Gerbaud, based in Saint-Maur-des-Fossés, France, is a prominent inventor known for her significant contributions to the field of virology, particularly concerning the severe acute respiratory syndrome (SARS) coronavirus. With a total of two patents to her name, her work has had a substantial impact on the understanding and potential treatment of viral infections.
Latest Patents
Among her notable inventions, Sylvie Gerbaud holds a patent for a novel strain of SARS-associated coronavirus, which originated from a sample collected in Hanoi, Vietnam. This invention, designated with the reference number 031589, encompasses nucleic acid molecules derived from the genome of the virus, along with proteins and peptides encoded by these molecules, specifically focusing on protein N. The applications of this invention include its use as diagnostic reagents and potential vaccine development, showcasing the critical role of her research in combating viral outbreaks.
Career Highlights
Throughout her career, Sylvie Gerbaud has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Université Paris 7. Her contributions within these institutions have supported advancements in scientific research and innovation.
Collaborations
Sylvie Gerbaud has collaborated with several notable experts in the field, including Sylvie Van Der Werf and Nicolas Escriou. These collaborations have further enriched her research and have contributed to the collective understanding of viral pathogenesis and immune response.
Conclusion
Sylvie Gerbaud's work exemplifies the importance of innovation in the medical field, particularly in the context of infectious diseases like SARS. Her patents not only represent significant scientific advancements but also hold the potential to influence future diagnostic and therapeutic strategies in virology. Through her research and collaborations, she continues to make valuable contributions to the fight against viral infections.